文献速递泌尿生殖MR

磁共振指纹成像在前列腺癌增强前后的应用

Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
PubMed 文献 · Br J Radiol · 2021-08-20

结果发现外周带各值均显著高于癌和移行带,移行带增强T1显著低于癌而其他值高于癌,增强后T1和部分T2值显著降低。结论认为MRF可用于前列腺定量分析,癌与正常组织间ADC及T1、T2值存在显著差异。

要点

  • 前列腺癌的ADC及MRF-derived T1、T2值均显著低于正常外周带。
  • 增强MRF可提供T1、T2定量值,且增强后T1值普遍降低。
  • 移行带与癌的定量值有差异,但增强T1在移行带更低,需注意鉴别。

关键影像表现/征象

  • 前列腺癌、正常外周带和正常移行带的ADC、平扫T1、平扫T2、增强T1、增强T2值被定量测量。
  • 正常外周带的ADC值和MRF-derived值均显著高于前列腺癌或移行带(p < 0.001)。
  • 移行带的增强T1显著低于前列腺癌,而其他变量值显著高于前列腺癌(p < 0.001)。
  • 增强MRF上三个区域的T1值以及前列腺癌和移行带的T2值均显著低于平扫MRF(p < 0.001)。

诊断标准与关键数值

  • 前列腺癌与正常外周带或移行带的ADC、平扫T1、平扫T2、增强T1、增强T2值差异均有统计学意义(p < 0.001)。
  • 增强与平扫MRF之间,三个区域T1值及前列腺癌和移行带T2值的差异均有统计学意义(p < 0.001)。

临床应用与阅片要点

  • 阅片时可关注MRF-derived T1、T2定量值辅助鉴别前列腺癌与正常组织。
  • 增强后T1值普遍降低,解读时应使用增强序列的参考值。
  • 移行带增强T1低于癌,需结合ADC及其他序列避免误判。

局限性

  • 原文未报告敏感度、特异度、AUC或诊断阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the apparent diffusion coefficient (ADC) values and the T1 and T2 values derived from nonenhanced (NE) and contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) in the prostate gland and to evaluate differences in values among prostate cancer, the normal peripheral zone (PZ) and the normal transition zone (TZ).

METHODS: Fifty-seven patients (median age, 73 years; range, 48-86) with prostate cancer who underwent multiparametric MRI including NE and CE MRF were included in this study. T1 and T2 values were extracted from NE and CE MRF, respectively. Five quantitative values (the ADC, NE T1, NE T2, CE T1 and CE T2 values) were measured in three areas: prostate cancer, PZ and TZ. We compared the values among the three areas and evaluated the differences between NE MRF and CE MRF values.

RESULTS: ADC values and MRF-derived values were significantly higher in PZ than prostate cancer or TZ (p < 0.001). TZ had a significantly lower CE T1 but significantly higher values of the other variables than prostate cancer (p < 0.001). The T1 values in all three areas and the T2 values in prostate cancer and TZ were significantly lower on CE MRF than on NE MRF (p < 0.001).

CONCLUSIONS: Quantitative analysis of NE and CE MRI can be conducted by using the MRF technique. The ADC value and the T1 and T2 values from CE MRF and NE MRF were found to be significantly different between prostate cancer and normal prostate tissue.

ADVANCES IN KNOWLEDGE: The T1 and T2 values from contrast-enhanced MR fingerprinting are significantly different between prostate cancer and normal prostate tissue.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee YS, Choi MH, Lee YJ, et al. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement. Br J Radiol. 2021. PMID: 34415785. doi:10.1259/bjr.20210479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。